Clinical meaning
Diabetic nephropathy (diabetic kidney disease) is a progressive kidney disease caused by chronic hyperglycemia and its downstream metabolic and hemodynamic effects. It is the leading cause of end-stage renal disease (ESRD) in developed countries, affecting 20-40% of patients with diabetes, and significantly increases cardiovascular morbidity and mortality. The pathogenesis begins with glomerular hyperfiltration. In the early stages of diabetes, chronic hyperglycemia increases renal blood flow and glomerular filtration rate (GFR) by 20-50% above normal. This hyperfiltration is driven by afferent arteriolar vasodilation (from glucose-mediated nitric oxide release and prostaglandins), efferent arteriolar vasoconstriction (from angiotensin II), and tubuloglomerular feedback disruption (glucose and sodium co-absorption in the proximal tubule reduces sodium delivery to the macula densa, triggering afferent dilation). The result is increased intraglomerular pressure that damages the filtration barrier over time. Hyperglycemia directly damages glomerular cells through several mechanisms. Advanced glycation end-products (AGEs) form when glucose non-enzymatically binds to proteins, lipids, and nucleic acids, creating cross-linked modified proteins that activate inflammatory pathways. The polyol pathway converts excess glucose to sorbitol via aldose reductase, causing osmotic cellular stress. Protein kinase C (PKC)...